Yabao Pharmaceutical Group Co., Ltd (SHA:600351)
China · Delayed Price · Currency is CNY 6.76
-0.15 (-2.17%)
Nov 13, 2026, 3:00 PM CST
SHA:600351 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 2,195 | 2,240 | 2,686 | 2,910 | 2,718 | 2,764 |
Revenue Growth | -3.46% | -16.60% | -7.69% | 7.05% | -1.66% | 6.21% |
Gross Profit Gross Profit Growth | 1,163 | 1,148 | 1,363 | 1,664 | 1,502 | 1,669 |
Operating Income Operating Income Growth | 338.7 | 310.77 | 277.18 | 291.5 | 178.07 | 196.65 |
Net Income Net Income Growth | 361.52 | 320.01 | 242.69 | 199.59 | 104.66 | 187.09 |
Earnings Per Share EPS Growth | 0.52 | 0.46 | 0.34 | 0.26 | 0.14 | 0.24 |
EPS Growth | 65.38% | 36.35% | 28.34% | 92.42% | -44.07% | 74.32% |
Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Medical Production Medical Production Growth | 1,796 |
Wholesale of Medicine Wholesale of Medicine Growth | 389.76 |
Other Trade Other Trade Growth | 23.87 |
Total Total Growth | 2,210 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 917.89 | 820.51 | 578.59 | 617.64 | 668.5 | 477.05 |
Total Debt Total Debt Growth | 3.8 | 36.15 | 95.7 | 209 | 441.65 | 538.74 |
Net Cash (Debt) Net Cash Growth | 914.09 | 784.36 | 482.9 | 408.64 | 226.85 | -61.69 |
Net Cash Growth | 65.31% | 62.43% | 18.17% | 80.14% | - | - |
Net Cash Per Share Net Cash Per Share Growth | 1.32 | 1.12 | 0.67 | 0.54 | 0.29 | -0.08 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 642.75 | 573.77 | 471.69 | 497.55 | 460.46 | 437.5 |
Capital Expenditures CapEx Growth | -33.89 | -48.85 | -34.66 | -99.86 | -62.23 | -95.05 |
Free Cash Flow Free Cash Flow Growth | 608.87 | 524.91 | 437.03 | 397.7 | 398.23 | 342.45 |
Free Cash Flow Growth | 21.57% | 20.11% | 9.89% | -0.13% | 16.29% | 7.66% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 53.00% | 51.26% | 50.73% | 57.19% | 55.27% | 60.39% |
Operating Margin | 15.43% | 13.87% | 10.32% | 10.02% | 6.55% | 7.12% |
Pretax Margin | 20.23% | 16.72% | 10.88% | 7.53% | 4.62% | 7.29% |
Profit Margin | 16.47% | 14.29% | 9.04% | 6.86% | 3.85% | 6.77% |
FCF Margin | 27.74% | 23.43% | 16.27% | 13.67% | 14.65% | 12.39% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.300 | 0.350 | 0.300 | 0.150 | 0.050 | 0.080 |
Dividend Per Share Growth | 0% | 16.67% | 100.00% | 200.00% | -37.50% | 60.00% |
Dividend Yield | 4.44% | 5.39% | 4.85% | 2.15% | 0.85% | 0.88% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 12.94 | 14.03 | 18.07 | 26.13 | 43.26 | 37.37 |
Forward PE | - | 15.89 | 15.89 | 15.89 | 15.89 | 15.89 |
P/FCF Ratio | 7.81 | 8.56 | 10.03 | 13.11 | 11.37 | 20.42 |
PS Ratio | 2.17 | 2.01 | 1.63 | 1.79 | 1.67 | 2.53 |